{
  "trial_id": "NCT00208520",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Adult patients with generalized tonic-clonic, complex partial and/or simple partial seizures.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Patients on valproate monotherapy who are not seizure free at at the maximal dose they can tolerate.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Patients should be able to understand the patient information concerning the study and be able to give informed consent.",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "exclusion": [
    {
      "criterion": "Absence seizures or juvenile myoclonic epilepsy",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "Acute or progressive neurological disorders",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Alcohol or other substance abuse",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "History of severe psychiatric illness",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "Patient has a history of epilepsy, CHF, and depression. He was recently tapered off Dilantin and had no further events during the hospital course.",
  "_meta": {
    "topic_id": "9",
    "trial_id": "NCT00208520",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}